Molecular mechanisms of apoptosis induced by a novel synthetic quinolinone derivative in HL-60 human leukemia cells. 2020

Joanna Drogosz-Stachowicz, and Angelika Długosz-Pokorska, and Katarzyna Gach-Janczak, and Agata Jaskulska, and Tomasz Janecki, and Anna Janecka
Department of Biomolecular Chemistry, Medical University of Łódź, 92-215, Łódź, Poland.

The mortality rates for acute myeloid leukemia are very high, necessitating the search for novel chemotherapeutic candidates. Herein, we investigated the anticancer potential of a new synthetic compound, 2-ethyl-3-methyliden-1-tosyl-2,3-dihydroquinolin-4-(1H)-one (AJ-374) against myeloid leukemia HL-60 cell line. This analog was selected from the small library of synthetic dihydroquinolinones on the basis of its strong antiproliferative activity against HL-60 cells and 30-fold lower cytotoxicity towards healthy HUVEC cells. AJ-374 promoted the arrest of the cells in the subG0/G1 phase of the cell cycle in the first 24 h. Treatment of HL-60 cells with AJ-374 caused an increase in annexin-V positive cells, activation of caspase-8, -9 and -3, dissipation of the mitochondrial membrane potential and enhancement of FAS protein level. Apoptosis induction triggered by this quinolinone was blocked by the pre-treatment of the cells with caspase-8, -9 and -3 inhibitors. The obtained results indicated that AJ-374-induced apoptosis was executed by both, the extrinsic and intrinsic pathways. The cytotoxic activity of AJ-374 was also associated with down-regulation of the mitogen-activated protein kinase (MAPK) pathway and was independent of reactive oxygen species generation. Taken together, these results suggest that AJ-374 exerts a potent anticancer effect on leukemia cells, with a wide safety margin, which makes this analog an attractive drug candidate for further testing.

UI MeSH Term Description Entries
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D053078 Membrane Potential, Mitochondrial The voltage difference, normally maintained at approximately -180mV, across the INNER MITOCHONDRIAL MEMBRANE, by a net movement of positive charge across the membrane. It is a major component of the PROTON MOTIVE FORCE in MITOCHONDRIA used to drive the synthesis of ATP. Delta Psi M,DeltaPsi M,DeltapsiM,Mitochondrial Membrane Potential,Mitochondrial Transmembrane Potential,M, DeltaPsi,Membrane Potentials, Mitochondrial,Mitochondrial Membrane Potentials,Mitochondrial Transmembrane Potentials,Transmembrane Potential, Mitochondrial,Transmembrane Potentials, Mitochondrial

Related Publications

Joanna Drogosz-Stachowicz, and Angelika Długosz-Pokorska, and Katarzyna Gach-Janczak, and Agata Jaskulska, and Tomasz Janecki, and Anna Janecka
July 1994, Experimental cell research,
Joanna Drogosz-Stachowicz, and Angelika Długosz-Pokorska, and Katarzyna Gach-Janczak, and Agata Jaskulska, and Tomasz Janecki, and Anna Janecka
August 2007, Ai zheng = Aizheng = Chinese journal of cancer,
Joanna Drogosz-Stachowicz, and Angelika Długosz-Pokorska, and Katarzyna Gach-Janczak, and Agata Jaskulska, and Tomasz Janecki, and Anna Janecka
March 1999, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Joanna Drogosz-Stachowicz, and Angelika Długosz-Pokorska, and Katarzyna Gach-Janczak, and Agata Jaskulska, and Tomasz Janecki, and Anna Janecka
May 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
Joanna Drogosz-Stachowicz, and Angelika Długosz-Pokorska, and Katarzyna Gach-Janczak, and Agata Jaskulska, and Tomasz Janecki, and Anna Janecka
January 1997, International journal of oncology,
Joanna Drogosz-Stachowicz, and Angelika Długosz-Pokorska, and Katarzyna Gach-Janczak, and Agata Jaskulska, and Tomasz Janecki, and Anna Janecka
February 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Joanna Drogosz-Stachowicz, and Angelika Długosz-Pokorska, and Katarzyna Gach-Janczak, and Agata Jaskulska, and Tomasz Janecki, and Anna Janecka
August 2010, Journal of hematology & oncology,
Joanna Drogosz-Stachowicz, and Angelika Długosz-Pokorska, and Katarzyna Gach-Janczak, and Agata Jaskulska, and Tomasz Janecki, and Anna Janecka
April 1997, The Journal of antibiotics,
Joanna Drogosz-Stachowicz, and Angelika Długosz-Pokorska, and Katarzyna Gach-Janczak, and Agata Jaskulska, and Tomasz Janecki, and Anna Janecka
December 2008, Toxicology letters,
Joanna Drogosz-Stachowicz, and Angelika Długosz-Pokorska, and Katarzyna Gach-Janczak, and Agata Jaskulska, and Tomasz Janecki, and Anna Janecka
January 2004, Biochemical pharmacology,
Copied contents to your clipboard!